Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,205.50
-0.80 (-0.04%)
At close: Dec 5, 2025
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 910.34 billion as of December 5, 2025. Its market cap has decreased by -12.54% in one year.
Market Cap
910.34B
Enterprise Value
961.47B
Revenue
135.46B
Ranking
n/a
PE Ratio
51.81
Stock Price
2,205.50
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 910.34B, an increase of 59.78%. That is a compound annual growth rate of 19.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 910.34B | -23.40% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,362.71B |
| Divi's Laboratories | 1,717.32B |
| Cipla | 1,228.62B |
| Apollo Hospitals Enterprise | 1,035.39B |
| Zydus Lifesciences | 941.58B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |
| Fortis Healthcare | 670.82B |